Furthermore, β-arrestin-biased TGR5 signaling was shown to promote NSCLC cell proliferation via YAP activation, contrasting with the anti-proliferative effects of Gs-biased signaling (95). Here, GPBAR1 is linked to non-small cell lung carcinoma.